Treatment of advanced cancer of the larynx and hypopharynx with chemoradiation

ANZ Journal of Surgery

Volumn 74, Issue 7, 2004, Pages 554-558

  Featherstone, Carolyn J ^a   Clarke, Stephen ^a   Jackson, Michael A ^a   Shannon, Kerwin F ^a   McNeil, Edward B ^a   Tin, Mo M ^a   Clifford, Anthony ^a   O'Brien, Christopher J ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Cancer; Chemoradiation; Hypopharynx; Larynx

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; FLUOROURACIL; TIRAPAZAMINE;

ADULT; ADVANCED CANCER; AGED; ARTERY THROMBOSIS; ARTICLE; AUSTRALIA; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CEREBROVASCULAR ACCIDENT; DATA ANALYSIS; DEATH; DYSPHAGIA; FEBRILE NEUTROPENIA; FOLLOW UP; HUMAN; HYPOPHARYNX CARCINOMA; KIDNEY FAILURE; LARYNGECTOMY; LARYNX CARCINOMA; LARYNX EDEMA; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PATIENT SELECTION; RADIATION NECROSIS; SURVIVAL RATE; THORAX PAIN; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES;

EID: 3442875332     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2004.03056.x     Document Type: Article

References (20)

1. Wolf GT, Waun K, Fisher SG et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department Veterans Affairs Laryngeal Cancer Study Group. N. Engl. J. Med. 1991; 324: 1685-90.
2. Lefebvre JL, Chevalier D, Luboniski B et al. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organisation for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J. Natl. Cancer Inst. 1996; 88: 890-9.
3. Cancer in New South Wales: Incidence and Mortality. NSW Central Cancer Registry, NSW Cancer Council, 2001.
4. Lundahl RE, Foote RL, Bonner JA et al. Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched pair analysis. Int. J. Radiat. Oncol. Biol. Phys. 1993; 26: 3-11.
5. Vikram B, Strong EW, Shah JP et al. Failure in the neck following mulitmodality treatment for advanced head and neck cancer. Head Neck Surg. 1984; 6: 724-9.
6. Hall GT, O'Brien CJ, Clifford AR et al. Clinical outcome following total laryngectomy for cancer. ANZ J. Surg. 2003; 73: 300-5.
7. Spaulding MB, Fischer SG, Wolf GT. Tumour response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group. J. Clin. Oocol. 1994; 12: 1592-9.
8. Kummermehr J, Dorr W, Trott KR. Kinetics of accelerated repopulation in normal and malignant squamous epithelia during fractionated therapy. BJR 1992; 24: 193-9.
9. Peters LJ, Withers HR. Applying radiobiological principles to combined modality treatment of head and neck cancer: the time factor. Int. J. Radiat. Oncol. Biol. Phys. 1997; 39: 831-6.
10. Pignon JP, Bourhis J, Domenge C et al. Chemotherapy added to loco-regional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. Lancet 2000; 355: 949-55.
11. Ang KK, Peters LJ, Weber RS et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oro- pharynx and nasopharynx. Int. J. Radiat. Oncol. Biol. Phys. 1990; 19: 1339-45.
12. Garden AS, Glisson BS, Ang KK et al. Phase I/II trial of radiation with chemotherapy 'boost' for advanced squamous cell carcinomas of the head and neck: toxicities and responses. J. Clin. Oncol. 1999; 17: 2390-5.
13. Cony J, Rischin D, Smith JG et al. Radiation with concurrent late chemotherapy intensification ('chemoboost') for locally advanced head and neck cancer. Radiother. Oncol. 2000; 54: 123-7.
14. Rischin D, Peters L, Hicks R et al. Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy, in patients with advanced head & neck cancer. J. Clin. Oncol. 2001; 19: 535-42.
15. Fu KK, Pajak TF, Trotti A et al. A Radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int. J. Radiat Oncol. Biol. Phys. 2000; 48: 7-16.
16. Wendt TG, Grabenbauer GG, Reodel CM et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized mulitcenter study. J. Clin. Oncol. 1998; 16: 1318-24.
17. Adams S, Baum RP, Stuckenson T et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur. J. Nucl. Med. 1998; 25: 1255-60.
18. Parsons JT, Mendenhall WM, Stringer SP et al. Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx. Int. J. Radiat. Oncol. Biol. Phys. 1995; 32: 605-9.
19. Lavertu P, Bonafede JP, Adelstein DJ et al. Comparison of surgical complications after organ preservation therapy in patients with stage 3 and 4 squamous cell carcinomas of the head and neck. Arch. Otolaryngol. Head Neck Surg. 1998; 124: 401-6.
20. Sassler AM, Esclamado RM, Wolf GT. Surgery after organ preservation therapy. Analysis of wound complications. Arch. Otolaryngol. Head Neck Surg. 1995; 121: 162-5.